Wongtanasarasin Wachira, Ungrungseesopon Nat, Namsongwong Nutthida, Chotipongkul Pongsatorn, Visavakul Onwara, Banping Napatsakorn, Kampeera Worapot, Phinyo Phichayut
Department of Emergency Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Nursing Service Division, Outpatient and Emergency Service Section, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand.
Turk J Emerg Med. 2022 Apr 11;22(2):67-74. doi: 10.4103/2452-2473.342805. eCollection 2022 Apr-Jun.
Calcium administration during cardiac arrest is limited in some circumstances, mainly due to lack of consistent evidence. This study aims to investigate whether calcium therapy administered during cardiac arrest at the Emergency Department is associated with good outcomes, including the probability of return of spontaneous circulation (ROSC), survival to hospital admission, survival to hospital discharge, and favorable neurological outcome at discharge.
We retrospectively reviewed 599 consecutive adult cardiac arrest events between 2016 and 2018. The primary outcome was the ROSC rate. Secondary outcomes included survival to hospital admission, survival to hospital discharge, and favorable neurologic outcome at hospital discharge. Multivariable logistic regression with inverse probability of treatment weighting was analyzed to examine the association between calcium administration and outcomes.
Of 599 events, calcium was administered in 72 (12%) cases. The use of calcium during cardiopulmonary resuscitation (CPR) after adjusting for confounding factors was not associated with any better outcomes, including ROSC (adjusted odds ratio (aOR) 0.53, 95% confidence interval [CI] 0.24-1.17), survival to hospital admission (aOR 1.07, 95% CI 0.47-2.41), survival to hospital discharge (aOR 1.93, 95% CI 0.43-8.56), and favorable neurological outcome (aOR 6.60, 95% CI 0.72-60.74). Besides, calcium use in traumatic cardiac arrest patients was associated with unfavorable outcomes, including ROSC (aOR 0.02, 95% CI 0.00-0.09) and survival to hospital admission (aOR 0.16, 95% CI 0.03-0.84).
The use of calcium during an adult cardiac arrest was not associated with better outcomes. Although associations drawn from this study did not indicate the causality, given calcium during CPR was linked to poorer outcomes in traumatic cardiac arrest patients, including ROSC and survival to hospital admission.
在某些情况下,心脏骤停期间使用钙剂受到限制,主要是由于缺乏一致的证据。本研究旨在调查急诊科心脏骤停期间给予钙剂治疗是否与良好的预后相关,包括自主循环恢复(ROSC)的概率、入院存活、出院存活以及出院时良好的神经功能预后。
我们回顾性分析了2016年至2018年间连续发生的599例成人心脏骤停事件。主要结局是ROSC率。次要结局包括入院存活、出院存活以及出院时良好的神经功能结局。采用多变量逻辑回归分析并进行治疗权重逆概率分析,以检验钙剂使用与结局之间的关联。
在599例事件中,72例(12%)给予了钙剂。在调整混杂因素后,心肺复苏(CPR)期间使用钙剂与任何更好的结局均无关联,包括ROSC(调整优势比[aOR]0.53,95%置信区间[CI]0.24 - 1.17)、入院存活(aOR 1.07,95% CI 0.47 - 2.41)、出院存活(aOR 1.93,95% CI 0.43 - 8.56)以及良好的神经功能结局(aOR 6.60,95% CI 0.72 - 60.74)。此外,创伤性心脏骤停患者使用钙剂与不良结局相关,包括ROSC(aOR 0.02,95% CI 0.00 - 0.09)和入院存活(aOR 0.16,95% CI 0.03 - 0.84)。
成人心脏骤停期间使用钙剂与更好的结局无关。尽管本研究得出的关联未表明因果关系,但鉴于CPR期间给予钙剂与创伤性心脏骤停患者的较差结局相关,包括ROSC和入院存活。